MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202514117546 A) filed by Zhuhai Trinomab Pharmaceutical Co. , Ltd. on November 26, 2025, for “a Formulation Comprising An Anti-Tetanus Toxin Antibody”.
Inventors include Zhao, Hao; Tan, Chaoqun; Zhou, Xia; Gong, Ping; Su, Siya; Wang, Yueming; Zheng, Weihong; and Liao, Huaxin.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present disclosure discloses a formulation comprising an anti-tetanus toxin antibody. The formulation comprises the anti-tetanus toxin antibody at a concentration of 1-100 mg/mL and has a pH value of 5.0-7.0; and optionally, the formulation further comprises one or more selected from the group consisting of a surfactant, a pH modifier, a protein protectant, and an osmolality modifier. The formulation provided by the present disclosure can effectively maintain the stability of the antibody, making it less prone to aggregation, and preventing oxidation, denaturation, and degradation; furthermore, it maintains the high potency of the antibody against tetanus toxin, possessing the high biological activity required for the prevention or treatment of tetanus.
Disclaimer: Curated by HT Syndication.
